Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes
暂无分享,去创建一个
B. Wayne Bequette | Faye Cameron | Gregory P. Forlenza | Bruce A. Buckingham | David M. Maahs | Darrell M. Wilson | B. Bequette | R. Beck | B. Buckingham | Paula K Clinton | H. Chase | J. Lum | D. Maahs | I. Hramiak | C. Kollman | G. Forlenza | T. Ly | M. Driscoll | H. Peter Chase | T. Spaic | Paula Clinton | Craig Kollman | Dan Raghinaru | Roy W. Beck | Tamara Spaic | Marsha Driscoll | Emily Jost | Irene Hramiak | Terri Paul | John W. Lum | Trang T. Ly | Dan Raghinaru | F. Cameron | Emily Jost | Terri Paul
[1] Darrell M. Wilson,et al. A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes , 2014, Diabetes Care.
[2] Laya Ekhlaspour,et al. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. , 2016, The lancet. Diabetes & endocrinology.
[3] Roman Hovorka,et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. , 2014, The lancet. Diabetes & endocrinology.
[4] Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp. , 2016, Diabetes technology & therapeutics.
[5] Tadej Battelino,et al. MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover Trial , 2014, Diabetes Care.
[6] Ahmad Haidar,et al. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. , 2015, The lancet. Diabetes & endocrinology.
[7] Janet M. Allen,et al. Day and Night Closed-Loop Control in Adults With Type 1 Diabetes , 2013, Diabetes Care.
[8] J. Giedt,et al. Rensselaer Polytechnic Institute , 1960, Nature.
[9] Claudio Cobelli,et al. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. , 2015, The lancet. Diabetes & endocrinology.
[10] David M Nathan,et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. , 2014, The New England journal of medicine.
[11] Darrell M. Wilson,et al. Inpatient Studies of a Kalman-Filter-Based Predictive Pump Shutoff Algorithm , 2012, Journal of diabetes science and technology.
[12] B. Buckingham,et al. Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp , 2016, Diabetes Care.
[13] R. Tanenberg,et al. Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[14] The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase , 1986, Diabetes.
[15] Hypoglycemia does not change the threshold for arousal from sleep in adolescents with type 1 diabetes. , 2012, Diabetes technology & therapeutics.
[16] Howard C. Zisser,et al. Feasibility of Outpatient Fully Integrated Closed-Loop Control , 2013, Diabetes Care.
[17] Ahmad Haidar,et al. Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes , 2013, Diabetes Care.
[18] Malgorzata E. Wilinska,et al. Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial , 2014, Diabetes Care.
[19] Dale E. Seborg,et al. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas , 2016, Diabetes Care.
[20] Marc D. Breton,et al. Multinational Home Use of Closed-Loop Control Is Safe and Effective , 2016, Diabetes Care.
[21] Roman Hovorka,et al. Day and Night Home Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes: Three-Center Randomized Crossover Study , 2014, Diabetes Care.
[22] Janet M. Allen,et al. Day and Night Closed-Loop Control in AdultsWith Type 1 Diabetes A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management , 2013 .
[23] Bruce Buckingham,et al. Response to nocturnal alarms using a real-time glucose sensor. , 2005, Diabetes technology & therapeutics.
[24] B. Wayne Bequette,et al. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis , 2015, Diabetes Care.
[25] Janet M. Allen,et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies , 2011, BMJ : British Medical Journal.
[26] E. Atlas,et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. , 2013, The New England journal of medicine.
[27] Multinight "bedside" closed-loop control for patients with type 1 diabetes. , 2015, Diabetes technology & therapeutics.
[28] Roman Hovorka,et al. Home Use of an Artificial Beta Cell in Type 1 Diabetes. , 2015, The New England journal of medicine.
[29] Darrell M. Wilson,et al. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. , 2013, Diabetes technology & therapeutics.
[30] D. B. Keenan,et al. The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes , 2012, Diabetes Care.
[31] Benyamin Grosman,et al. Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp , 2015, Diabetes Care.
[32] Roman Hovorka,et al. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents , 2014, BMJ Open Diabetes Research and Care.
[33] Marc D. Breton,et al. Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp , 2014, Diabetes Care.
[34] D. BretonMarc,et al. Multinight "bedside" closed-loop control for patients with type 1 diabetes. , 2015 .
[35] T. Jones,et al. Decreased epinephrine responses to hypoglycemia during sleep. , 1998, The New England journal of medicine.
[36] Marc D. Breton,et al. Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas , 2014, Diabetes Care.